POLYMED Q1 FY27 results at a glance
POLY MEDICURE LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹525 cr |
|---|
| Revenue YoY | +30.3% |
|---|
| Operating profit | ₹88.84 cr |
|---|
| Operating margin | 16.9% |
|---|
| Net profit | ₹86.03 cr |
|---|
| Net profit YoY | -7.6% |
|---|
| Net profit QoQ | +32.3% |
|---|
| Net margin | 16.4% |
|---|
| Basic EPS | ₹8.49 |
|---|
| TTM revenue | ₹1,997 cr |
|---|
| TTM net profit | ₹314 cr |
|---|
| TTM net margin | 15.7% |
|---|
POLYMED Q1 FY27 results: what the numbers say
POLY MEDICURE LIMITED (POLYMED) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹525 cr and a net profit of ₹86.03 cr, translating into earnings per share of ₹8.49.
Compared with the same quarter a year earlier, revenue grew strongly by +30.3% and net profit declined by -7.6%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹88.84 cr, an operating margin of 16.9% versus 20.6% a year ago — a contraction of 3.6 percentage points.
POLYMED quarter-wise results table
Net profit
₹86.03 cr
-7.6% YoY
Operating profit
₹88.84 cr
+7.2% YoY
POLY MEDICURE LIMITED (POLYMED) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹525 cr | ₹88.84 cr | ₹86.03 cr | 16.9% | 16.4% | ₹8.49 | -7.6% | +32.3% |
| Q4 FY262026-03-31 | ₹535 cr | ₹72.17 cr | ₹65.04 cr | 13.5% | 12.2% | ₹6.54 | — | -8.3% |
| Q3 FY262025-12-31 | ₹494 cr | -₹74.35 cr | ₹70.93 cr | -15.1% | 14.4% | ₹7.00 | — | -22.8% |
| Q2 FY262025-09-30 | ₹444 cr | ₹89.75 cr | ₹91.84 cr | 20.2% | 20.7% | ₹9.06 | — | -1.3% |
| Q1 FY262025-06-30 | ₹403 cr | ₹82.88 cr | ₹93.08 cr | 20.6% | 23.1% | ₹9.19 | — | — |
| TTM (last 4 quarters) | ₹1,997 cr | ₹176 cr | ₹314 cr | 8.8% | 15.7% | ₹31.09 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
POLYMED quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
POLY MEDICURE LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹525 cr | ₹535 cr | ₹494 cr | ₹444 cr | ₹403 cr |
|---|
| Total expenses | ₹437 cr | ₹462 cr | ₹568 cr | ₹354 cr | ₹320 cr |
|---|
| Gross profit | ₹386 cr | ₹356 cr | ₹181 cr | ₹308 cr | ₹276 cr |
|---|
| Operating profit (EBIT) | ₹88.84 cr | ₹72.17 cr | -₹74.35 cr | ₹89.75 cr | ₹82.88 cr |
|---|
| Operating margin | 16.9% | 13.5% | -15.1% | 20.2% | 20.6% |
|---|
| Interest cost | ₹6.5 cr | ₹6.41 cr | ₹5.96 cr | ₹2.97 cr | ₹2.95 cr |
|---|
| Profit before tax | ₹117 cr | ₹85.22 cr | ₹97.61 cr | ₹122 cr | ₹123 cr |
|---|
| Tax expense | ₹32.03 cr | ₹20.18 cr | ₹26.8 cr | ₹29.89 cr | ₹29.86 cr |
|---|
| Effective tax rate | 27.3% | 23.7% | 27.5% | 24.6% | 24.3% |
|---|
| Net profit (PAT) | ₹86.03 cr | ₹65.04 cr | ₹70.93 cr | ₹91.84 cr | ₹93.08 cr |
|---|
| Net profit margin | 16.4% | 12.2% | 14.4% | 20.7% | 23.1% |
|---|
| Basic EPS | ₹8.49 | ₹6.54 | ₹7.00 | ₹9.06 | ₹9.19 |
|---|
| Diluted EPS | ₹8.48 | ₹6.53 | ₹6.99 | ₹9.06 | ₹9.17 |
|---|
POLYMED results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +30.3% | — | — | — | — |
|---|
| Revenue QoQ | -1.7% | +8.3% | +11.2% | +10.1% | — |
|---|
| Operating profit YoY | +7.2% | — | — | — | — |
|---|
| Operating profit QoQ | +23.1% | +197.1% | -182.8% | +8.3% | — |
|---|
| Net profit YoY | -7.6% | — | — | — | — |
|---|
| Net profit QoQ | +32.3% | -8.3% | -22.8% | -1.3% | — |
|---|
| EPS YoY | -7.6% | — | — | — | — |
|---|
| EPS QoQ | +29.8% | -6.6% | -22.7% | -1.4% | — |
|---|
POLYMED annual results history
Full-year performance for POLY MEDICURE LIMITED, useful for reading each quarter in context.
POLY MEDICURE LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,875 cr | ₹1,670 cr | ₹1,366 cr | ₹1,109 cr |
|---|
| Total expenses | ₹1,548 cr | ₹1,300 cr | ₹1,063 cr | ₹891 cr |
|---|
| Gross profit | ₹1,278 cr | ₹1,114 cr | ₹761 cr | ₹599 cr |
|---|
| Operating profit (EBIT) | ₹327 cr | ₹370 cr | ₹303 cr | ₹218 cr |
|---|
| Operating margin | 17.4% | 22.2% | 22.2% | 19.6% |
|---|
| Interest cost | ₹18.29 cr | ₹12 cr | ₹10.7 cr | ₹8.54 cr |
|---|
| Profit before tax | ₹427 cr | ₹453 cr | ₹344 cr | ₹237 cr |
|---|
| Tax expense | ₹96.18 cr | ₹114 cr | ₹86.01 cr | ₹58.21 cr |
|---|
| Effective tax rate | 22.5% | 25.2% | 25.0% | 24.5% |
|---|
| Net profit (PAT) | ₹331 cr | ₹339 cr | ₹258 cr | ₹179 cr |
|---|
| Net profit margin | 17.7% | 20.3% | 18.9% | 16.2% |
|---|
| Basic EPS | ₹31.79 | ₹34.13 | ₹26.92 | ₹18.69 |
|---|
| Diluted EPS | ₹31.75 | ₹34.11 | ₹26.90 | ₹18.67 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹525 cr against ₹403 cr in Q1 FY26, and ₹535 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -1.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹437 cr, or 83.1% of revenue, with operating profit grew +7.2% year on year.
Margins, tax and profitability
Net profit of ₹86.03 cr works out to a net margin of 16.4% compared with 23.1% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, POLY MEDICURE LIMITED reported profit before tax of ₹117 cr, a tax charge of ₹32.03 cr (effective rate 27.3%), interest cost of ₹6.5 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹65.04 cr in Q4 FY26 to ₹86.03 cr in Q1 FY27, a change of +32.3%.
Trailing twelve months and annual context
Across the trailing four quarters POLY MEDICURE LIMITED has generated revenue of ₹1,997 cr and net profit of ₹314 cr, a trailing net margin of 15.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,875 cr with net profit of ₹331 cr and EPS of ₹31.79, versus the prior year where revenue grew +12.3% and profit declined -2.1%.
What to watch in the next POLYMED quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
POLY MEDICURE LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
POLYMED results coverage
No results report published for POLYMED yet — our desk covers each quarter within minutes of the filing.
POLYMED quarterly results FAQs
What were POLY MEDICURE LIMITED (POLYMED) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), POLY MEDICURE LIMITED reported revenue of ₹525 cr and net profit of ₹86.03 cr, a change of -7.6% year on year on +30.3% revenue growth. EPS stood at ₹8.49.
What is POLYMED profit margin in Q1 FY27?
POLY MEDICURE LIMITED posted a net profit margin of 16.4% and an operating margin of 16.9% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,997 cr and net profit ₹314 cr.
Did POLYMED results beat the previous quarter?
POLY MEDICURE LIMITED net profit changed +32.3% quarter on quarter, from ₹65.04 cr in Q4 FY26 to ₹86.03 cr in Q1 FY27.
When are POLY MEDICURE LIMITED (POLYMED) quarterly results?
POLY MEDICURE LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see POLYMED latest quarterly results?
Results coverage for POLYMED will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the POLYMED stock page.
What is POLY MEDICURE LIMITED annual revenue and profit?
For FY26, POLY MEDICURE LIMITED reported full-year revenue of ₹1,875 cr and net profit of ₹331 cr, with EPS of ₹31.79.
How many quarterly results has POLYMED declared recently?
Past results dates for POLYMED will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
